title: Potential savings by reduced CD4 monitoring in stable patients with HIV receiving antiretroviral therapy.
authors: Emily P
authors: EP
authors: Hyle
authors: Paul E
authors: PE
authors: Sax
authors: Rochelle P
authors: RP
authors: Walensky
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000191:economics / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count / Q000191:economics; D017046:Cost Savings; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics* / Q000453:epidemiology; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic / Q000191:economics*; D009017:Morbidity / Q000639:trends; D014481:United States / Q000453:epidemiology; D055815:Young Adult
chemical_list: D044966:Anti-Retroviral Agents
references: MMWR Morb Mortal Wkly Rep. 2011 Dec 2;60(47):1618-23
references: 22129997
references: Curr Opin Infect Dis. 2013 Feb;26(1):17-25
references: 23221765
references: Clin Infect Dis. 2013 May;56(9):1340-3
references: 23315315
references: Clin Infect Dis. 2013 Apr;56(8):1174-82
references: 23315317